Cargando…

Refractory invasive aspergillosis controlled with posaconazole and pulmonary surgery in a patient with chronic granulomatous disease: case report

Invasive aspergillosis is an important cause of morbidity and mortality in immunocompromised patients. Among primary immunodefiencies, chronic granulomatous disease (CGD) has the highest prevalence of invasive fungal diseases. Voriconazole is recommended for the primary treatment of invasive aspergi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kepenekli, Eda, Soysal, Ahmet, Kuzdan, Canan, Ermerak, Nezih Onur, Yüksel, Mustafa, Bakır, Mustafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914384/ https://www.ncbi.nlm.nih.gov/pubmed/24401677 http://dx.doi.org/10.1186/1824-7288-40-2

Ejemplares similares

Successful treatment of allergic bronchopulmonary aspergillosis with posaconazole in a child with cystic fibrosis: Case report and review of the literature
por: Yakut, Nurhayat, et al.
Publicado: (2020)

Rahnella aquatilis Sepsis in a Premature Newborn
por: Kuzdan, Canan, et al.
Publicado: (2015)

Intraventricular Ciprofloxacin Usage in Treatment of Multidrug-Resistant Central Nervous System Infections: Report of Four Cases
por: Karaaslan, Ayşe, et al.
Publicado: (2014)

Recurrent Candida albicans Ventriculitis Treated with Intraventricular Liposomal Amphotericin B
por: Toprak, Demet, et al.
Publicado: (2015)

Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole
por: Soysal, Ahmet
Publicado: (2015)

Validity and Reliability of the Turkish Version of the Nuss Questionnaire Modified for Adults
por: Bahadir, A. Tugba, et al.
Publicado: (2015)

Compliance of Healthcare Workers with Hand Hygiene Practices in Neonatal and Pediatric Intensive Care Units: Overt Observation
por: Karaaslan, Ayşe, et al.
Publicado: (2014)

Recurrent Bacterial Meningitis in a Child with Mondini Dysplasia
por: Kepenekli-Kadayifci, Eda, et al.
Publicado: (2014)

Atypical Presentation of Cat-Scratch Disease in an Immunocompetent Child with Serological and Pathological Evidence
por: Atıcı, Serkan, et al.
Publicado: (2014)

The Clinical Efficacy and Safety of Ertapenem for the Treatment of Complicated Urinary Tract Infections Caused by ESBL-Producing Bacteria in Children
por: Karaaslan, Ayse, et al.
Publicado: (2015)

Epstein-Barr Virus Encephalitis in an Immunocompetent Child: A Case Report and Management of Epstein-Barr Virus Encephalitis
por: Akkoc, Gulsen, et al.
Publicado: (2016)

Bacteremia due to Acinetobacter ursingii in infants: Reports of two cases
por: Yakut, Nurhayat, et al.
Publicado: (2016)

Pharmacology and metabolism of voriconazole and posaconazole in the treatment of invasive aspergillosis-review of the literature
por: Sandherr, M, et al.
Publicado: (2011)

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
por: Karthaus, M
Publicado: (2011)

Posaconazole in the management of refractory invasive fungal infections
por: Langner, Stefan, et al.
Publicado: (2008)

Invasive aspergillosis in a patient with end stage renal disease
por: Cicek, Neslihan, et al.
Publicado: (2017)

Treatment of Disseminated Aspergillosis with Posaconazole in 10 Dogs
por: Corrigan, V.K., et al.
Publicado: (2016)

Postoperative keratitis due to Paecilomyces: a rare pediatric case
por: Toker, Ebru, et al.
Publicado: (2016)

Anesthesia Management for a Patient Undergoing Pulmonary Endarterctomy without Cardiopulmonary Bypass
por: Saracoglu, Ayten, et al.
Publicado: (2019)

Braın abscess due to Streptococcus intermedius secondary to mastoiditis in a child
por: Yakut, Nurhayat, et al.
Publicado: (2015)

Granulomatous response to invasive pulmonary aspergillosis in an immunotherapy-naive host, a maladaptive response?
por: Mora Carpio, Andres L., et al.
Publicado: (2018)

Invasive Pulmonary Aspergillosis with Marked Eosinophilia as a Unique Presentation of Chronic Granulomatous Disease
por: Van Woensel, Julie, et al.
Publicado: (2022)

Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report
por: Verfaillie, Saartje, et al.
Publicado: (2022)

Aspergillosis in Chronic Granulomatous Disease
por: King, Jill, et al.
Publicado: (2016)

Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis
por: Martínez-Casanova, Javier, et al.
Publicado: (2018)

Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole
por: Bunskoek, Paulien E., et al.
Publicado: (2017)

Diagnosis by metagenomic next-generation sequencing of invasive pulmonary aspergillosis in an infant with chronic granulomatous disease
por: Yang, Aimei, et al.
Publicado: (2022)

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

Posaconazole treatment of refractory coccidioidomycosis in dogs
por: Shubitz, Lisa F., et al.
Publicado: (2021)

Ventilator-associated pneumonia caused by Chryseobacterium indologenes: a rare infant case and review of the literature
por: Atıcı, Serkan, et al.
Publicado: (2016)

Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis
por: Leelawattanachai, Pannee, et al.
Publicado: (2019)

Posaconazole for the prophylaxis of invasive aspergillosis in acute myeloid leukemia: Is it still useful outside the clinical trial setting?
por: Chen, Tsung-Chih, et al.
Publicado: (2020)

Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis
por: Maertens, Johan A., et al.
Publicado: (2023)

Cerebral aspergillosis and pulmonary tuberculosis in a child with chronic granulomatous disease
por: Waqas, Muhammed, et al.
Publicado: (2016)

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial
por: Vanderbeke, Lore, et al.
Publicado: (2021)

358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)
por: Cheng, Matthew P, et al.
Publicado: (2018)

1169. In Vitro Activity of Posaconazole versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults Enrolled in a Clinical Trial
por: Castanheira, Mariana, et al.
Publicado: (2020)

Erratum for “Posaconazole treatment of refractory coccidioidomycosis in dogs”
Publicado: (2022)

Invasive Pulmonary Aspergillosis
por: Ledoux, Marie-Pierre, et al.
Publicado: (2023)

Invasive Aspergillosis in Refractory Angioimmunoblastic T-Cell Lymphoma
por: NP, Prakash, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hhn0bp7ttl43i4jm3h6uhdt7bp